Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7217
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone ; volume:176 ; number:2 ; day:30 ; month:4 ; year:2019 ; pages:377-386 ; date:7.2019
Breast cancer research and treatment ; 176, Heft 2 (30.4.2019), 377-386, 7.2019
- Urheber
-
Sestak, Ivana
Martín, Miguel
Dubsky, Peter
Kronenwett, Ralf
Rojo, Federico
Cuzick, Jack
Filipits, Martin
Ruiz, Amparo
Gradishar, William
Soliman, Hatem
Schwartzberg, Lee
Buus, Richard
Hlauschek, Dominik
Rodríguez-Lescure, Alvaro
Gnant, Michael
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10549-019-05226-8
- URN
-
urn:nbn:de:101:1-2019102120475332159892
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sestak, Ivana
- Martín, Miguel
- Dubsky, Peter
- Kronenwett, Ralf
- Rojo, Federico
- Cuzick, Jack
- Filipits, Martin
- Ruiz, Amparo
- Gradishar, William
- Soliman, Hatem
- Schwartzberg, Lee
- Buus, Richard
- Hlauschek, Dominik
- Rodríguez-Lescure, Alvaro
- Gnant, Michael
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cytomorphological Disparities in Invasive Breast Cancer Cells following Neoadjuvant Endocrine Therapy and Chemotherapy
![Endocrine therapy of breast cancer, [1]](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Endocrine therapy of breast cancer, [1]
Endocrine therapy of breast cancer, 3
Endocrine management of cancer, 2.. Contemporary therapy
Metastatic breast cancer: Endocrine therapy landscape reshaped
Temporal influence of endocrine therapy with tamoxifen and chemotherapy on nutritional risk and obesity in breast cancer patients
Endocrine therapy and growth regulation of breast cancer
Endocrine therapy: defining the path of least resistance
Status of adjuvant endocrine therapy for breast cancer
GLYATL1 PROMOTES ENDOCRINE THERAPY RESISTANCE IN BREAST CANCER
VAV3 mediates resistance to breast cancer endocrine therapy
Endocrine
Cytomorphological Disparities in Invasive Breast Cancer Cells following Neoadjuvant Endocrine Therapy and Chemotherapy
Endocrine therapy of breast cancer, [1]
Endocrine therapy of breast cancer, 3
Endocrine management of cancer, 2.. Contemporary therapy
Metastatic breast cancer: Endocrine therapy landscape reshaped
Temporal influence of endocrine therapy with tamoxifen and chemotherapy on nutritional risk and obesity in breast cancer patients
Endocrine therapy and growth regulation of breast cancer
Endocrine therapy: defining the path of least resistance
Status of adjuvant endocrine therapy for breast cancer
GLYATL1 PROMOTES ENDOCRINE THERAPY RESISTANCE IN BREAST CANCER
VAV3 mediates resistance to breast cancer endocrine therapy
Endocrine
Cytomorphological Disparities in Invasive Breast Cancer Cells following Neoadjuvant Endocrine Therapy and Chemotherapy
Endocrine therapy of breast cancer, [1]
Endocrine therapy of breast cancer, 3
Endocrine management of cancer, 2.. Contemporary therapy
Metastatic breast cancer: Endocrine therapy landscape reshaped
Temporal influence of endocrine therapy with tamoxifen and chemotherapy on nutritional risk and obesity in breast cancer patients
Endocrine therapy and growth regulation of breast cancer
Endocrine therapy: defining the path of least resistance
Status of adjuvant endocrine therapy for breast cancer
GLYATL1 PROMOTES ENDOCRINE THERAPY RESISTANCE IN BREAST CANCER
VAV3 mediates resistance to breast cancer endocrine therapy